COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States

Rick Greene, MD, and Adam Berger, MD, discuss a shift away from nonurgent and preventative medical care due to the pandemic, related changes in presentation of melanoma patients in surgical clinics, and the likely impact on melanoma diagnoses and prognoses. Dr. Berger is author of, “COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States.” Dr. Berger is Chief of Melanoma for the multidisciplinary Melanoma and Soft Tissue Surgical Oncology Program at the Rutgers Cancer Institute of New Jersey and Professor of Surgery at Rutgers Robert Wood Johnson Medical School.